PM-C-Brea

PepMix™ Collection Breast Cancer

US$4,904.00

Currently out of stock, available again soon

Description

About PepMix™ Collection Breast Cancer

Collection of 8 peptide pools derived from scans (overlapping peptides scans, 15mers with 11 aa overlap) through 8 tumor associated antigens (breast cancer markers: CEA, Claudin-6, ErbB2_ECD, ErbB2_ICD, MAGEA3, Mammaglobin A, Mucin-1, MMP11) of Homo sapiens plus 2 control pools (CEF Pool (extended) and Actin)

PepMix™ Collection Breast Cancer - Specifications

Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 10⁸ cells)
Purity: Development Grade: each peptide purified to > 70% (HPLC/MS)
(equivalent to an average purity of 85%)
Delivery Format: Freeze-dried in 10 glass vials
Application(s): T-cell Immunity, Cancer biomarker research
Condition(s)/Topic(s): Breast cancer, Cancer
Standard Delivery Time: 2-5 days

This PepMix Collection contains 8 different TAA PepMixes:

+ 2 Controls

Are you interested in your own custom PepMix? Choose your sequence, amount, purity and pool format. We will assist you along the way. Custom PepMix Peptide Pools.

PepMix™ Peptide Pools
Protein-spanning mixtures of overlapping peptides (PepMix™) are extremely efficient for
- Antigen-specific T cell stimulation in T cell assays (e.g. in ELISpot, ICS, cell-mediated cytotoxicity or proliferation assays)
- In-vitro T cell expansion
- Dendritic cell pulsing
- Immune monitoring
- Cellular immune response profiling
- T cell epitope identification
- Standardization of T cell assays

Benefits of PepMix™
- Production ISO 9001 certified
- Each peptide quality controlled and guaranteed for identity and purity
- CoA and HPLC-MS data available
- High batch-to-batch consistency
- No false positive T cell responses by contaminating deletion peptides
- No toxic inhibition of T cell responses due to stringent purification of each peptide
- Minimization of endotoxin contamination due to low bioburden process
- ADCF policy in place
- HLA independent stimulation (with antigen spanning peptide pools)

References

References for PepMix™ Collection Breast Cancer

References
Read References with
PepMix™ Peptide Pools for Tumor Associated Antigens
PepMix™ Control Pools

Application Notes
Peptide Tools to Support the Fight against COVID-19
Alem et al (2020) Full text
Developing Multi-HIV Antigen Specific T-Cells as a Component of a Cure Strategy
Lam et al. (2015) Full text
Peptide-stimulated Expansion of Virus-specific T cells For Preventative Treatment After Allogeneic Stem Cell Transplantation
Gary et al. (2015) Full text

Testimonials
"To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides."
Dr. Laura J Pallett, Infection and Immunity, University College London, UK

Documentation

Properties

Properties of PepMix™ Collection Breast Cancer

Properties	Values
Amount:	25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)
Application:	Cancer biomarker research, T-cell immunity
Category:	PepMix Collections, PepMix Peptide Pools
Condition / Topic:	Breast cancer, Cancer
Layout:	Freeze-dried in 10 glass vials, Freeze-dried in glass vial
Organism:	Human
Protein Name:	Selected proteins
Purity:	>70% (HPLC-MS), Development Grade: each peptide purified to > 70% (HPLC/MS)
Quantification:	Yes

Further Information to PepMix™ Collection Breast Cancer

Information	Values
Sequence:	8 different TAA PepMixes + 2 Controls (15mers, overlap 11): Human (CEA), Human (Claudin-6), Human (ErbB2_ECD), Human (ErbB2_ICD), Human (MAGEA3), Human (Mammaglobin A), Human (Mucin-1), Human (Stromelysin-3, MMP11),CEF Pool (extended), Human (Actin)
Specifications:	Peptide scan (15mers with 11 aa overlap); CEF control pool selected 9 mer peptides